Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14555 | 696 | 35.1 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
392 | 16284 | LONG QT SYNDROME//BRUGADA SYNDROME//QT INTERVAL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TORSADES DE POINTES | Author keyword | 15 | 16% | 12% | 85 |
2 | TORSADE DE POINTES | Author keyword | 14 | 16% | 11% | 79 |
3 | ELECT ENGN CYBERNET | Address | 9 | 83% | 1% | 5 |
4 | EARLY AFTERDEPOLARIZATIONS | Author keyword | 9 | 30% | 3% | 24 |
5 | EARLY AFTERDEPOLARIZATION | Author keyword | 9 | 27% | 4% | 28 |
6 | BEAT TO BEAT VARIABILITY OF REPOLARIZATION | Author keyword | 8 | 70% | 1% | 7 |
7 | ATRIAL FIBERS | Author keyword | 8 | 100% | 1% | 5 |
8 | MONOPHASIC ACTION POTENTIAL | Author keyword | 7 | 17% | 5% | 38 |
9 | CHRONIC AV BLOCK DOG | Author keyword | 6 | 80% | 1% | 4 |
10 | CHRONIC ATRIOVENTRICULAR BLOCK DOG | Author keyword | 6 | 100% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EARLY AFTERDEPOLARIZATIONS | 26 | 20% | 18% | 122 |
2 | TORSADES DE POINTES | 22 | 13% | 22% | 154 |
3 | TO BEAT VARIABILITY | 17 | 55% | 3% | 21 |
4 | DEPENDENT EARLY AFTERDEPOLARIZATIONS | 15 | 50% | 3% | 22 |
5 | FEMALE RABBIT HEART | 15 | 68% | 2% | 13 |
6 | TRIGGERED ACTIVITY | 13 | 17% | 10% | 72 |
7 | COMPLETE AV BLOCK | 13 | 55% | 2% | 16 |
8 | POTENTIAL DURATION PROLONGATION | 9 | 55% | 2% | 12 |
9 | ISETHIONATE | 7 | 36% | 2% | 16 |
10 | D SOTALOL | 7 | 17% | 5% | 35 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Macrolide Antibiotics and the Risk of Cardiac Arrhythmias | 2014 | 13 | 69 | 42% |
Cardiac risks associated with antibiotics: azithromycin and levofloxacin | 2015 | 1 | 45 | 44% |
Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts | 2008 | 34 | 81 | 73% |
Assessing predictors of drug-induced torsade de pointes | 2003 | 136 | 46 | 39% |
The cardiotoxicity of macrolides: a systematic review | 2010 | 10 | 44 | 70% |
Arrhythmias associated with fluoroquinolone therapy | 2007 | 38 | 26 | 42% |
Antibiotic-induced Cardiac Arrhythmias | 2014 | 4 | 67 | 43% |
Beat-to-beat variability of repolarization as a new biomarker for proarrhythmia in vivo | 2012 | 11 | 56 | 63% |
QT Prolongation and Torsade de Pointes Induced by Fluoroquinolones: Infrequent Side Effects from Commonly Used Medications | 2011 | 15 | 33 | 39% |
Preclinical Torsades-de-Pointes screens: Advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk | 2008 | 28 | 67 | 45% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ELECT ENGN CYBERNET | 9 | 83% | 0.7% | 5 |
2 | CARDIOVASC SAFETY PHARMACOL | 4 | 67% | 0.6% | 4 |
3 | EXCELLENCE CARDIOVASC SAFETY | 3 | 35% | 0.9% | 6 |
4 | CLIN EXOT PETS REPTILES EXOT FERAL BIRDS | 2 | 67% | 0.3% | 2 |
5 | GLOBAL PRECLIN TOXICOL PATHOL | 2 | 67% | 0.3% | 2 |
6 | SAFETY PHARMACOL | 2 | 13% | 2.3% | 16 |
7 | CENT PROJECT GRP ZPG 4A | 2 | 43% | 0.4% | 3 |
8 | CARDIOVASC MEDOTA KU | 1 | 50% | 0.3% | 2 |
9 | SAFETY ASSESSMENT UK | 1 | 13% | 1.0% | 7 |
10 | ANIM WELFARE COMPLIANCE | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000254039 | DOFETILIDE//MS 551//SOTALOL |
2 | 0.0000213315 | HERG//HUMAN ETHER A GO GO RELATED GENE//HERG CHANNEL |
3 | 0.0000205088 | QT DISPERSION//QT INTERVAL//THOROUGH QT STUDY |
4 | 0.0000200161 | LONG QT SYNDROME//KCNQ1//SHORT QT SYNDROME |
5 | 0.0000186590 | SERTINDOLE//PSYCHOPHARMACOL VENTURE//TROP TOXINOL UNIT |
6 | 0.0000157193 | RANOLAZINE//LATE SODIUM CURRENT//LATE I NA |
7 | 0.0000131420 | CISAPRIDE//KW 5092//CINITAPRIDE |
8 | 0.0000121117 | OPTICAL MAPPING//BIDOMAIN MODEL//BIDOMAIN |
9 | 0.0000110226 | TRANSMEMBRANE BEHAVIOR//AG STRAHLENPHYS//BIOINORGAN INORGAN DRUG CHEM |
10 | 0.0000093356 | OVARIAN SEX HORMONES//PARTNERSHIP WOMENS HLTH//NOLL 106 |